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Abstract
Background: Particulate matter (PM) can exacerbate allergic airway diseases. Although health
effects of PM with a diameter of less than 100 nm have been focused, few studies have elucidated
the correlation between the sizes of particles and aggravation of allergic diseases. We investigated
the effects of nano particles with a diameter of 14 nm or 56 nm on antigen-related airway
inflammation.
Methods: ICR mice were divided into six experimental groups. Vehicle, two sizes of carbon nano
particles, ovalbumin (OVA), and OVA + nano particles were administered intratracheally. Cellular
profile of bronchoalveolar lavage (BAL) fluid, lung histology, expression of cytokines, chemokines,
and 8-hydroxy-2'-deoxyguanosine (8-OHdG), and immunoglobulin production were studied.
Results: Nano particles with a diameter of 14 nm or 56 nm aggravated antigen-related airway
inflammation characterized by infiltration of eosinophils, neutrophils, and mononuclear cells, and
by an increase in the number of goblet cells in the bronchial epithelium. Nano particles with antigen
increased protein levels of interleukin (IL)-5, IL-6, and IL-13, eotaxin, macrophage chemoattractant
protein (MCP)-1, and regulated on activation and normal T cells expressed and secreted (RANTES)
in the lung as compared with antigen alone. The formation of 8-OHdG, a proper marker of
oxidative stress, was moderately induced by nano particles or antigen alone, and was markedly
enhanced by antigen plus nano particles as compared with nano particles or antigen alone. The
aggravation was more prominent with 14 nm of nano particles than with 56 nm of particles in
overall trend. Particles with a diameter of 14 nm exhibited adjuvant activity for total IgE and
antigen-specific IgG1 and IgE.
Conclusion:  Nano particles can aggravate antigen-related airway inflammation and
immunoglobulin production, which is more prominent with smaller particles. The enhancement
may be mediated, at least partly, by the increased local expression of IL-5 and eotaxin, and also by
the modulated expression of IL-13, RANTES, MCP-1, and IL-6.
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Introduction
Previous epidemiological studies have indicated that
long-term exposure to ambient particulate matter (PM) is
linked to increases in mortality and morbidity related to
respiratory diseases [1,2]. The concentration of PM of
mass median aerodynamic diameter (a density-depend-
ent unit of measure used to describe the diameter of the
particle) < or 10 µm (PM10) is related to daily hospital
admissions for asthma, acute and chronic bronchiolitis,
and lower respiratory tract infections [3]. PM of mass
median aerodynamic diameter < or 2.5 µm (PM2.5) are
more closely associated with both acute and chronic res-
piratory effects and subsequent mortality than PM10 [4].
Our laboratory has researched health effects of diesel
exhaust particles (DEP), main constituents of PM2.5 in
urban areas, especially in vivo. We have reported that DEP
exacerbate allergic asthma [5] and acute lung injury
related to bacterial infection in murine models [6].
Recently, nano particles, particles less than 0.1 µm in mass
median aerodynamic diameter, have been implicated to
affect cardiopulmonary systems [4,7]. Indeed, two in vivo
studies have demonstrated that nano particles induce
prominent airway inflammation as compared with larger
particles [8,9]. Nano particles which have a larger surface
area than the particles with larger size are able to penetrate
deeply into the respiratory tract and cause a greater
inflammatory response [10,11].
Bronchial asthma has been recognized as chronic airway
inflammation that is characterized by an increase in the
number of activated lymphocytes and eosinophils. A
number of studies have shown that various particles
including carbon black (CB) can enhance allergic sensiti-
zation [12-14]. CB has been demonstrated to enhance
proliferation of antibody forming cells and both IgE and
IgG levels [15,16]. Ultrafine particles (PM and CB) report-
edly exaggerate allergic airway inflammation in vivo
[17,18]. However, all the studies have not described the
size of particles they used. Therefore, no research has been
addressed the size effects of particles or nano particles on
allergic airway inflammation in vivo.
The aim of the present study was to elucidate the effects of
two sizes of carbon nano particles (14 nm or 56 nm) on
allergic airway inflammation, local expression of
cytokines, chemokines, and 8-hydroxy-2'-deoxyguanos-
ine (8-OHdG), and production of total IgE and antigen-
specific IgG1, IgG2a, and IgE.
Materials and methods
Animals
Male ICR mice 6 to 7 wk of age and weighing 29 to 33 g
(Japan Clea Co., Tokyo, Japan) were used in all experi-
ments. They were fed a commercial diet (Japan Clea Co.)
and given water ad libitum. Mice were housed in an ani-
mal facility that was maintained at 24 to 26°C with 55 to
75% humidity and a 12-h light/dark cycle.
Study protocol
Mice were divided into six experimental groups (Fig. 1).
The vehicle group received phosphate-buffered saline
(PBS) at pH 7.4 (Nissui Pharmaceutical Co., Tokyo,
Japan) containing 0.05% Tween 80 (Nakalai Tesque,
Kyoto, Japan) once a week for 6 wk. The ovalbumin
(OVA) group received 1 µg of OVA (Sigma Chemical, St.
Louis, MO) dissolved in the same vehicle every 2 wk for 6
wk. The nano particle groups received 50 µg of nano par-
ticles (14 nm: PrinteX 90 or 56 nm: PrinteX 25, degussa,
Dusseldorf, Germany) suspended in the same vehicle
every week for 6 wk. The OVA + nano particle groups
received the combined treatment in the same protocol as
the OVA and the nano particle groups, respectively. The
surface area of the 14 nm nano particles was 300 m2/g and
that of 56 nm nano particles was 45 m2/g. The size of each
particle was quantified by JEM-2010 transmission elec-
tron microscope (TEM; JEOL, Tokyo, Japan). Nano parti-
cles were autoclaved at 250°C for 2 h before use. The
suspension was sonicated for 3 min using an Ultrasonic
disrupter (UD-201; Tomy Seiko, Tokyo, Japan). In each
group, vehicle, OVA, nano particles, or OVA + nano parti-
cles was dissolved in 0.1 ml aliquots, and inoculated by
the intratracheal route through a polyethylene tube under
anesthesia with 4% halothane (Hoechst, Japan, Tokyo,
Japan). The animals were studied 24 h after the last intrat-
racheal administration, with lung histology, bronchoalve-
olar lavage (BAL), protein levels of cytokines and
chemokines in the lung tissue supernatants, immunohis-
tochemistry for 8-OHdG, and with Igs. The studies
adhered to the National Institutes of Health guidelines for
the experimental use of animals. All animal studies were
approved by the Institutional Review Board.
Study Protocol Figure 1
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Blood retrieval and analysis
Mice were anesthetized with diethyl ether. The chest and
abdominal walls were opened, and blood was retrieved by
cardiac puncture. Serum was prepared and frozen at –
80°C until assayed for total IgE and antigen-specific IgG1,
IgG2a, and IgE.
Histologic evaluation
After exsanguinations, the lungs were fixed by intratra-
cheal instillation with 10% neutral phosphate-buffered
formalin at a pressure of 20 cm H2O for at least 72 h.
Slices 2 to 3 mm thick of all pulmonary lobes were
embedded in paraffin. Sections 3 µm thick were stained
with Diff-Quik (International Reagents Co., Kobe, Japan)
or periodic acid-Schiff (PAS) and examined by two of us
(HT and KI) in a blind fashion.
Morphometric analysis for numbers of eosinophils, 
neutrophils, mononuclear cells, and goblet cells around the 
airways
Sections were stained with Diff-Quik to quantitate the
numbers of infiltrated eosinophils, neutrophils, and
mononuclear cells. The length of the basement mem-
brane of the airways was measured by videomicrometer
(Olympus, Tokyo, Japan) in each sample slide. The
number of eosinophils, neutrophils, and mononuclear
cells around the airways were counted with a micrometer
under oil immersion. Results were expressed as the
number of inflammatory cells per millimeter of basement
membrane as described previously [5].
To quantitate goblet cells, sections were stained with PAS.
The number of goblet cells in the bronchial epithelium
was counted by micrometer. Results were expressed as the
number of goblet cells per millimeter of basement mem-
brane as described previously [5].
BAL
The trachea was cannulated after the collection of blood.
The lungs were lavaged with 1.2 ml of sterile saline at
37°C, instilled bilaterally by syringe. The lavage fluid was
harvested by gentle aspiration. This procedure was con-
ducted two more times. The average volume retrieved was
90 % of the 3.6 ml that was instilled; the amounts did not
differ by treatment. The fluid collections were combined
and cooled to 4°C. The lavage fluid was centrifuged at 300
g for 10 min, and the total cell count was determined on
a fresh fluid specimen using a hemocytometer. Differen-
tial cell counts were assessed on cytologic preparations.
Slides were prepared using an Autosmear (Sakura Seiki
Co., Tokyo, Japan) and were stained with Diff-Quik
(International reagents Co.). A total of 500 cells were
counted under oil immersion microscopy.
Quantitation of cytokine and chemokine protein levels in 
the lung tissue supernatants
In a separate series of experiments, the animals were
exsanguinated and the lungs were subsequently
homogenized with 10 mM potassium phosphate buffer
(pH 7.4) containing 0.1 mM ethylenediaminetetraacetic
acid (Sigma, St Louis MO), 0.1 mM phenylmeth-
anesulphonyl fluoride (Nacalai Tesque, Kyoto, Japan), 1
µM pepstatin A (Peptide Institute, Osaka, Japan) and 2
µM leupeptin (Peptide Institute) as described previously
[5]. The homogenates were then centrifuged at 105,000 g
for 1 h. The supernatants were stored at -80°C. Enzyme-
linked immunosobent assays (ELISA) for interleukin (IL)-
4 (Amersham, Buckinghamshire, UK), IL-5 (Endogen,
Cambridge, MA), IL-6 (Biosource, Nivelles, Belgium), IL-
13, eotaxin, macrophage chemoattractant protein (MCP)-
1, and regulated on activation and normal T cells
expressed and secreted (RANTES: R&D systems, Minneap-
olis, MN) in the lung tissue supernatants were conducted
using matching antibody pairs according to the manufac-
ture's instruction. The second antibodies were conjugated
to horseradish peroxidase. Subtractive reading of 550 nm
from the reading at 450 nm were converted to pg/ml using
values obtained from standard curves generated with var-
ying concentrations of recombinant IL-4, IL-5, IL-6, IL-13,
eotaxin, MCP-1, and RANTES, with limits of detection of
5 pg/ml, 5 pg/ml, 3 pg/ml, 1.5 pg/ml, 2 pg/ml 2 pg/ml,
and 2 pg/ml, respectively.
Immunohistochemistry
The production of 8-OHdG in the lung was detected by
immunohistochemical analysis (n = 8 in each group)
using anti-8-OHdG polyclonal antibody (Japan Institute
for the Control of Aging, Shizuoka, Japan) as described
previously [19,20]. Deparaffinized slides were blocked
with 10% goat serum for 1 h. After blocking, anti-8-
OHdG antibody (0.5 µg/ml) was incubated with the sec-
tions for 1 h at room temperature, followed by the incu-
bation of a biotinylated secondary antibody and
streptavidin-peroxidase conjugate. Then, the slides were
incubated with 3-amino, 9-ethyl-carbazole chromogen,
and counterstained with hematoxylin in AutoProbe III kit
(Biomeda, Foster City, CA, USA). For each of the lung
specimens, the extent and intensity of staining with anti-
8-OHdG antibodies were graded on a scale of 0–4+ by two
blinded observers on two separate occasions using coded
slides as previously described [21]. A 4+ grade implies
maximally intense staining, whereas 0 implies no
staining.
Antigen-specific IgG determination
Antigen-specific IgG1 or IgG2a antibodies were measured
by ELISA with solid-phase antigen [5,22]. In brief, micro-
plate wells (Dynatech, Chantilly, VA) were coated with
OVA overnight at 4°C and then incubated at roomRespiratory Research 2005, 6:106 http://respiratory-research.com/content/6/1/106
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temperature for 1 h with PBS containing 1% bovine serum
albumin (BSA; Sigma) containing 0.01% thimerosal
(Nakalai Tesque). After washing, diluted samples were
introduced to the microplate and incubated at room tem-
perature for 1 h. After another washing, the wells were
incubated at room temperature for 1 h with biotinylated
rabbit anti-mouse IgG1 or IgG2a (Zymed Laboratories, San
Francisco, CA). After yet another washing, the wells were
incubated with horseradish-peroxidase-conjugated
streptavidin (Sigma) at room temperature for 1 h. The
wells were then washed and incubated with o-phenylene-
diamine and H2O2 in dark at room temperature for 30
min. The enzyme reaction was stopped with 4 N H2SO4.
Absorbance was read at 492 nm. Each plate incubated a
previously screened standard plasma that contained a
high titer of anti-OVA antibodies. The results were
expressed in titers, calculated based on the titers of the
standard plasma. Cut off values for antibody-positive
plasma were set to hold as the mean value of absorbance
of preimmune plasma.
Total IgE and antigen-specific IgE determination
Antigen-specific IgE antibody was measured by IgE-cap-
ture ELISA [5,22]. In brief, microplate wells were coated
with a rat anti-mouse IgE monoclonal antibody (Yamasa
Syoyu Co., Chiba, Japan) at 37°C for 3 h and then incu-
bated at 37°C for 1 h with 1% BSA-PBS and 0.01% thime-
rosal. After washing with PBS containing 0.05% Tween 20
(PBST; Nacalai Tesque), diluted samples were introduced
to the microplate and incubated overnight at 4°C. After
washing with PBST, biotinylated OVA was added to each
well and incubated for 1 h at room temperature with β-D-
galactosidase-conjugated streptavidin (Zymed). After the
final washing, the wells were incubated with 4-methylum-
belliferyl-β-galactoside (Sigma) as the enzyme substrate at
37°C for 2 h. The enzyme reaction was stopped with 0.1
M glycine-NaOH (pH, 10.3). The fluorescene intensity
was read by a microplate fluorescene reader (Fluoroskan
Flow Laboratories, Costa Mesa, CA). Each plate included
a previously screened standard plasma that contained a
high titer of anti-OVA antibodies. The results were
expressed in titers, calculated based on the titers of the
standard plasma. Cut off values for antibody-positive
plasma were set two hold as mean fluorescene units of
preimmune plasma. Total IgE was measured by capture
ELISA in a manner similar to the detection of antigen-spe-
cific IgE. A biotinylated rat anti-mouse IgE (BD Bio-
sciences Pharmingen, San Diego, CA) was used to detect
captured IgE in place of biotinylated OVA. A450 readings of
the samples were converted to nanograms per milliliter
using a standard curve generated with double dilutions of
mouse IgE κ isotype standard (BD Biosciences
Pharmingen).
Statistical analysis
Data were reported as mean ± SEM. Differences in the
numbers of infiltrated inflammatory cells and goblet cells,
cytokine protein levels, and immunogloblin concentra-
tions and titers between groups were determined using
analysis of variance (Stat view version 4.0; Abacus
Concepts, Inc., Berkeley, CA) as described previously [5].
If differences between groups were significant (P < 0.05),
Fisher's protected least significant difference test was used
to distinguish between pairs of groups.
Results
Effects of nano particles on antigen-related airway 
inflammation
To evaluate the effect of nano particles on antigen-related
airway inflammation, we investigated the cellular profile
of BAL fluid and lung histology.
The numbers of total cells and macrophages were signifi-
cantly greater in the nano particle, OVA, and OVA + nano
particle groups than in the vehicle group (P < 0.01: Table
1). Furthermore, the numbers were significantly greater in
Table 1: Cellular profile in bronchoalveolar lavage fluid.
Group Animals (n) Total Cells (× 104/total 
BAL)
Macrophages (× 104/
total BAL)
Eosinophils (× 104/
total BAL)
Neutrophils (× 104/
total BAL)
Mononuclear Cells 
(× 104/total BAL)
vehicle 16 36.88 ± 3.56 36.74 ± 3.53 0 ± 0 0.12 ± 0.05 0.015 ± 0.01
14 nm 13 111.69 ± 9.27** 83.79 ± 6.03** 0.332 ± 0.176 27.04 ± 4.98** 0.491 ± 0.201*
56 nm 14 97.36 ± 16.06** 88.64 ± 15.34** 0.331 ± 0.177 8.09 ± 2.49* 0.265 ± 0.093
OVA 16 85.06 ± 12.63** 81.91 ± 12.4** 0.705 ± 0.255 2.2 ± 0.62 0.121 ± 0.059
OVA + 14 nm 16 193.69 ± 18.33** ## $$ 141.86 ± 14.97** ## $ 13.667 ± 4.731** ## 
$
36.9 ± 3.67** ## $ 0.878 ± 0.232** #
OVA + 56 nm 17 102.65 ± 11.64** 90.7 ± 10.12** 3.984 ± 2.669 7.79 ± 2.29* 0.204 ± 0.073
Six groups of mice were intratracheally administered with vehicle, ovalbumin (OVA), nano particles, or combinations of OVA and nano particles for 
6 wk. Bronchoalveolar lavage (BAL) was conducted 24 h after the last intratracheal instillation. Total cell counts were determined on fresh BAL 
fluid, and differential cell counts were assessed with Diff-Quik-staining. Results are presented as mean ± SEM. *P < 0.05 versus vehicle, **P < 0.01 
versus vehicle, #P < 0.05 versus OVA, ##P < 0.01 versus OVA. $P < 0.05 versus nano particles. $$P < 0.01 versus nano particles.Respiratory Research 2005, 6:106 http://respiratory-research.com/content/6/1/106
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the OVA + 14 nm nano particle group than in the OVA
group or the 14 nm particle group (P < 0.01: Table 1).
Although the numbers were greater in the OVA + 56 nm
nano particle group than in the OVA group or the 56 nm
nano particle group, the difference did not achieve signif-
icance. OVA challenge increased the number of eosi-
nophils as compared with vehicle challenge without
significance. The numbesr of eosinophils were greater in
the OVA + nano particle groups than in the vehicle group
(P < 0.05 for OVA + 14 nm nano particle, N. S. for OVA +
56 nm nano particle). The number was significantly
greater in the OVA + 14 nm nano particle group than in
the OVA group (P < 0.01) or 14 nm nano particle group
(P < 0.05). The number was also greater in the OVA + 56
nm nano particle group than in the OVA group or 56 nm
nano particle group, but the difference did not achieve sig-
nificance. Challenge with nano particles significantly ele-
vated the numbers of neutrophils as compared with
vehicle challenge (P < 0.01 for 14 nm, P < 0.05 for 56
nm). OVA also elevated the number without significance
as compared with vehicle challenge. The number was sig-
nificantly greater in the OVA + 14 nm nano particle group
than in the 14 nm nano particle group (P < 0.05) or the
OVA group (P < 0.01). The number was also greater in the
OVA + 56 nm nano particle group than in the nano parti-
cle group or the OVA group, the difference did not reach
significance. Challenge with nano particles elevated the
numbers of mononuclear cells as compared with vehicle
challenge (P < 0.05 for 14 nm, N. S. for 56 nm). OVA also
elevated the number of mononuclear cells without signif-
icance as compared with vehicle challenge. The number
was significantly greater in the OVA + 14 nm nano particle
group than in the vehicle (P < 0.01) or the OVA group (P
< 0.05). The number was greater in the OVA + 56 nm nano
particle group than in the OVA group, but difference did
not achieve significance. There were no significant differ-
ences between the nano particle groups and OVA + nano
particle groups.
The magnitude and cellular profiles of airway inflamma-
tion were also evaluated in lung specimens stained with
Diff-Quik. Intratracheal instillation of nano particles pro-
vided diffuse deposition of the particles into the bilateral
lungs, including the bronchi and alveolar spaces. The par-
ticles were occasionally present within the subepithelial
neutrophils and alveolar macrophages. The combined
instillation of OVA + 14 nm nano particles for 6 wk led to
a marked infiltration of eosinophils and mononuclear
cells around the bronchi and bronchioles. OVA + 56 nm
nano particles also induced severe airway inflammation,
but the severity was less than that of OVA + 14 nm nano
particles. Either OVA or nano particles alone resulted in
slight recruitment of eosinophils and neutrophils. Vehicle
administration caused little infiltration of inflammatory
cells.
To quantitate the infiltration of inflammatory cells
around the airways, we expressed the number of these
cells per length of basement membrane of the airways
(Table 2). The number of eosinophils was greater in the
OVA group than in the vehicle group without significance.
The number of eosinophils was significantly greater in the
OVA + 14 nm nano particle group than in the vehicle, the
14 nm nano particle, or the OVA group (P < 0.01). The
number was greater also in the OVA + 56 nm nano particle
group than in the OVA group or the 56 nm nano particle
group, but the difference did not achieve significance.
OVA increased the number of neutrophils as compared
with vehicle challenge without significance. In the pres-
ence of OVA, nano particles with a diameter of 14 nm sig-
nificantly increased the number as compared with vehicle
or OVA challenge (P < 0.01 for vehicle, P < 0.05 for
OVA)). In the presence of OVA, nano particles with a
Table 2: Numbers of inflammatory cells and goblet cells in lung tissue.
Group Animals Eosinophils Neutrophils Mononuclear Cells Goblet Cells
(n) (n/mm)
vehicle 8 0.187 ± 0.064 0.616 ± 0.140 0.495 ± 0.224 0.177 ± 0.070
14 nm 8 1.419 ± 0.466 3.825 ± 1.073 ** 2.431 ± 0.736 * 0.243 ± 0.068
56 nm 7 0.252 ± 0.055 1.710 ± 0.426 0.967 ± 0.418 2.510 ± 2.249
OVA 6 2.442 ± 0.761 1.671 ± 0.222 2.546 ± 0.479 * 5.262 ± 4.150
OVA + 14 nm 6 7.252 ± 2.745 ** ## $$ 4.144 ± 0.795 ** # 5.393 ± 0.560 ** ## $$ 17.141 ± 6.702 ** # $$
OVA + 56 nm 6 3.022 ± 0.830 2.546 ± 0.563 * 2.202 ± 1.086 12.932 ± 3.230 * $
Animals received intratracheal instillation of vehicle, nano particles, OVA, or OVA + nano particles for 6 wk. Lungs were removed and fixed 24 h 
after the last intratracheal administration. Sections were stained with Diff-Quik for measurement of inflammatory cells around the airways or with 
PAS for goblet cells in the bronchial epithelium. Results are expressed as numbers of cells per length of basement membrane of airways. Values are 
mean ± SEM. *P < 0.05 versus vehicle, **P < 0.01 versus vehicle, #P < 0.05 versus OVA, ##P < 0.01 versus OVA. $P < 0.05 versus nano particles. $$P 
< 0.01 versus nano particles.Respiratory Research 2005, 6:106 http://respiratory-research.com/content/6/1/106
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diameter of 56 nm increased the number as compared
with vehicle (P < 0.05) or OVA (N. S.). Challenge with
nano particles increased the numbers as compared with
vehicle challenge (P < 0.01 for 14 nm nano particle, N. S.
for 56 nm nano particle). There were no significant differ-
ences between the OVA + nano particle groups and the
nano particle groups. The number of mononuclear cells
was significantly greater in the OVA group than in the
vehicle group (P < 0.05). 14 nm nano particles signifi-
cantly increased the number (P < 0.05 versus vehicle). The
number was significantly greater in the OVA + 14 nm
group than in the OVA group or the 14 nm nano particle
group (P < 0.01). The number was also greater in the OVA
+ 56 nm nano particle group than in the 56 nm nano par-
ticle group (P < 0.05) or the OVA group, but the difference
did not reach statistical significance.
Nano particles increase goblet cells after antigen 
challenge
To evaluate airway epithelial injury and hypersecretion of
mucus, lung sections were stained with PAS (Table 2).
OVA plus 56 nm nano particles increased the number of
goblet cells as compared with vehicle without signifi-
cance. The number was significantly greater in the OVA +
14 nm nano particle group than in the vehicle (P < 0.01),
the OVA (P < 0.05), or the 14 nm nano particle group (P
< 0.01). The number was greater also in the OVA + 56 nm
nano particle group than in the vehicle (P < 0.05), the
OVA (N. S.), or the 56 nm nano particle group (P < 0.05).
Effects of nano particles on local expression of Th2 
cytokines in the presence of antigen
To explore the role of local expression of Th2 cytokines in
the effects of nano particles on antigen-related airway
inflammation, we quantitated protein levels of IL-5, IL-4,
and IL-13 in the lung tissue supernatants (Table 3). OVA
challenge increased the level of IL-5 as compared with
vehicle challenge without significance. In the presence of
OVA, nano particles significantly elevated levels of IL-5 as
compared with vehicle (P < 0.01) or OVA (P < 0.05 for 56
nm, P < 0.01 for 14 nm). The levels were significantly
greater in the OVA + nano particle groups than in the
nano particle groups (P < 0.01). The levels of IL-13 were
significantly greater in the OVA + 14 nm nano particle
group than in the OVA group or 14 nm nano particle
group (P < 0.01). The levels were greater also in the OVA
+ 56 nm nano particle group than in the OVA group (N.
S.) or the 56 nm nano particle group (P < 0.05). The level
of IL-4 was significantly lower in the OVA + 56 nm nano
particle group than in the OVAgroup (P < 0.05). There
were no other significant differences among the experi-
mental groups.
Effects of nano particles on local expression of eotaxin, 
MCP-1, RANTES, and IL-6 in the presence of antigen
To investigate the local expression of eotaxin, MCP-1,
RANTES, and IL-6, we measured protein levels of these
cytokine and chemokines in the lung tissue supernatants
(Table 4). OVA challenge increased the levels of eotaxin
without significance as compared with vehicle challenge.
The levels were significantly greater in the OVA + nano
particle groups than in the vehicle (P < 0.01), the nano
particle group (P < 0.05 for OVA + 56 nm nano particle, P
< 0.01 for OVA + 14 nm nano particle), or the OVA (P <
0.05 for OVA + 56 nm nano particle, P < 0.01 for OVA +
14 nm nano particle) group. Nano particle challenge
increased the levels of MCP-1 as compared to vehicle
challenge (P < 0.01 for 14 nm, N. S. for 56 nm). OVA chal-
lenge slightly increased the levels without significance as
compared with vehicle challenge. Nano particles com-
bined with OVA enhanced the level as compared with
nano particle alone (P < 0.01 for 14 nm nano particle, N.
S. for 56 nm nano particle) or OVA alone (P < 0.01 for
OVA + 14 nm nano particle group, P < 0.05 for OVA + 56
Table 3: Protein levels of Th2 cytokines in the lung tissue supernatants.
Group Animals IL-5 IL-13 IL-4
(n) (pg/total lung tissue supernatants)
vehicle 16 5.5 ± 1.1 4.0 ± 1.1 204.3 ± 13.1
14 nm 13 4.6 ± 1.9 7.4 ± 4.3 194.7 ± 12.8
56 nm 14 7.1 ± 1.9 21.1 ± 8.9 204.3 ± 12.5
OVA 16 26.8 ± 11.1 16.2 ± 7.3 216.5 ± 14.8
OVA + 14 nm 16 113.7 ± 32.0** ## $ 120.3 ± 42.4** ## $ 178.5 ± 16.2
OVA + 56 nm 17 88.8 ± 38.0** # $ 61.8 ± 27.5* 170.8 ± 17.6#
Six groups were intratracheally inoculated with vehicle, nano particles, OVA, or the combination of OVA and nano particles for 6 wk. Lungs were 
removed and frozen 24 h after the last intratracheal administration. Protein levels in the lung tissue supernatants were analyzed using ELISA. Results 
are shown as mean ± SEM. *P < 0.05 versus vehicle, **P < 0.01 versus vehicle, #P < 0.05 versus OVA, ##P < 0.01 versus OVA. $P < 0.05 versus nano 
particles. $P < 0.01 versus nano particles.Respiratory Research 2005, 6:106 http://respiratory-research.com/content/6/1/106
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nm nano particle group). The levels of RANTES were sig-
nificantly greater in the OVA + nano particle groups than
in the vehicle group (P < 0.01 for OVA + 14 nm nano par-
ticle, P < 0.05 for OVA + 56 nm nano particle), or the OVA
group (P < 0.01 for OVA + 14 nm nano particle, P < 0.05
for OVA + 56 nm nano particle), or the nano particle
groups (P < 0.01 for 14 nm, N. S. for 56 nm). The levels of
IL-6 were significantly greater in the OVA + 14 nm and
OVA + 56 nm nano particle groups than in the vehicle
group (P < 0.01), the OVA group (P < 0.01 for OVA + 14
nm nano particle group, P < 0.05 for OVA + 56 nm nano
particle group), or the nano particle groups (P < 0.01).
Effects of nano particles on 8-OHdG formations in the 
presence or absence of antigen
We next studied 8-OHdG formation generated from deox-
yguanosine in DNA by oxidative stress in the lung. In the
vehicle group, nuclear staining with 8-OHdG was barely
detectable (Fig. 2A). Nano particles or OVA challenge
induced moderate staining with 8-OHdG (Fig. 2B, C, D).
On the other hand, OVA plus nano particles resulted in
intense immunoreactive 8-OHdG staining as compared to
OVA or nano particles alone (Fig. 2E, F). The intensity and
the extent of the immunoreactivity were more prominent
in the OVA + 14 nm nano particle group (Fig. 1E) than in
the OVA + 56 nm nano particle group (Fig. 2F). As typi-
cally shown in the OVA + nano particle groups, we found
the expression of 8-OHdG in macrophages phagocyting
nano particles as well as polymorphonuclear leukocytes
(Fig. 2E, F).
We performed morphometric analysis to quantitate the
extent and intensity of immunoreactive 8-OHdG among
the experimental groups. As compared to vehicle treat-
ment (immunohistochemical score, mean ± SEM: 0.8 ±
0.3), nano particles or OVA treatment revealed increased
immunoreactivity (14 nm nano particle: 2.0 ± 0.4, P <
0.05 versus vehicle; 56 nm nano particle: 1.5 ± 0.2; OVA:
1.9 ± 0.5). The scores were greater in OVA + nano particle
groups (OVA + 14 nm nano particle group: 2.9 ± 0.6; OVA
+ 56 nm nano particle group: 2.5 ± 0.3) than in the vehicle
(P < 0.01), OVA, or nano particle groups.
Effects of nano particles on adjuvant activity for total IgE 
and antigen-specific production of IgG and IgE
To exanime whether nano particles have adjuvant activity
for total IgE and antigen-specific Ig production, we meas-
ured total IgE and antigen-specific IgG1, IgG2a, and IgE
(Table 5). Total IgE levels were significantly greater in the
OVA + nano particle groups than in the vehicle group (P
< 0.01 for OVA + 14 nm nano particle group, P < 0.05 for
OVA + 56 nm nano particle group). The levels were also
significantly greater in the OVA + 14 nm nano particle
group than in the OVA or the 14 nm nano particle group
(P < 0.05). The antigen-specific IgG1 was significantly
greater in the OVA + 14 nm nano particle group than in
the other groups (P < 0.01 versus each other group). The
antigen-specific IgG2a  was not significantly different
among the experimental groups. The combination of OVA
plus 14 nm nano particles significantly increased antigen-
specific production of IgE as compared with vehicle or
OVA alone (P < 0.05).
Discussion
The present study demonstrated that nano particles
administered by the intratracheal route enhanced airway
inflammation associated with antigen challenge in mice.
The inflammatory component was characterized by
increased numbers of eosinophils, neutrophils, and
mononuclear cells. Recruitment of these cells was accom-
panied by an increment in goblet cells in the bronchial
epithelium. The airway inflammation induced by the
combined administration of nano particles with antigen
modulated local expression of IL-5, eotaxin, IL-13,
Table 4: Protein levels of eotaxin, MCP-1, RANTES, and IL-6 in the lung tissuesupernatants.
Group Animals eotaxin MCP-1 RANTES IL-6
(n) (pg/total lung tissue supernatants)
vehicle 16 67.9 ± 2.9 20.8 ± 3.5 174.6 ± 15.8 105.8 ± 3.6
14 nm 13 99.4 ± 7.1 239.0 ± 17.4** 192.3 ± 18.0 151.7 ± 8.2
56 nm 14 89.5 ± 9.2 89.3 ± 7.4 201.6 ± 22.1 106.5 ± 4.9
OVA 16 130.9 ± 32.3 41.9 ± 9.2 160.7 ± 17.1 118.3 ± 5.7
OVA + 14 nm 16 804.8 ± 175.7** ## $$ 542.8 ± 45.4** ## $$ 432.6 ± 27.8** ## $$ 297.7 ± 30.2** ## $$
OVA + 56 nm 17 399.1 ± 86.9** # $ 124.0 ± 14.1** # 235.4 ± 16.8* # 202.4 ± 54.2** # $$
Six groups were intratracheally inoculated with vehicle, nano particles, OVA, or the combination of OVA and nano particles for 6 wk. Lungs were 
removed and frozen 24 h after the last intratracheal administration. Protein levels in the lung tissue supernatants were analyzed using ELISA. Results 
are shown as mean ± SEM. *P < 0.05 versus vehicle, **P < 0.01 versus vehicle, #P < 0.05 versus OVA, ##P < 0.01 versus OVA. $P < 0.05 versus nano 
particles. $$P < 0.01 versus nano particles.Respiratory Research 2005, 6:106 http://respiratory-research.com/content/6/1/106
Page 8 of 12
(page number not for citation purposes)
RANTES, MCP-1, and IL-6. The formation of 8-OHdG was
moderately induced by nano particles or antigen alone,
and was further enhanced by antigen plus nano particles
as compared with nano particles or antigen alone. The
enhancing effects were more prominent with 14 nm nano
particles than with 56 nm nano particles. Furthermore, 14
nm nano particles enhanced total IgE and antigen-specific
production of IgG1 and IgE.
DEP exacerbate allergic diseases including allergic asthma
[5]. Elementary carbon, which is mainly involved in the
nuclei of DEP, can enhance allergic sensitization. We used
CB in the present study, since CB is a useful prototypical
particle for the research on the effects and their mecha-
nisms of PM including DEP. Because CB is relatively inert,
the effects of particle size can be elucidated without con-
founding factors [23]. Al-Humadi and coworkers have
Immunohistological staining for 8-hydroxy-2'-deoxyguanosine (8-OHdG) in the lung obtained from (A) vehicle group, (B) 14  nm nano particle group, (C) 56 nm nano particle group, (D) OVA group, (E) OVA + 14 nm nano particle group, and (F) OVA  + 56 nm nano particle group (n = 8 in each group) Figure 2
Immunohistological staining for 8-hydroxy-2'-deoxyguanosine (8-OHdG) in the lung obtained from (A) vehicle group, (B) 14 
nm nano particle group, (C) 56 nm nano particle group, (D) OVA group, (E) OVA + 14 nm nano particle group, and (F) OVA 
+ 56 nm nano particle group (n = 8 in each group). Lungs were removed twenty-four h after the last intratracheal instillation. 
Arrows denote positive staining. Original magnification × 300.
Table 5: Levels of total IgE and antigen-specific IgG1, IgG2a, and IgE.
Group Animals (n) Total IgE (ng/ml) Antigen-Specific IgG1 
(titers)
Antigen-Specific IgG2a 
(titers)
Antigen-Specific IgE 
(fluorescene intensity)
vehicle 12 93.8 ± 27.5 485.3 ± 274.2 152.1 ± 48.8 625.2 ± 49.3
14 nm 9 152.3 ± 36.1 1880.3 ± 1656.2 163.5 ± 49.2 698.7 ± 61.0
56 nm 11 304.1 ± 127.4 1128.2 ± 717.1 182.5 ± 72.9 610.9 ± 54.1
OVA 10 443.4 ± 173.2 2178.5 ± 910.7 256.7 ± 206.2 576.2 ± 89.3
OVA + 14 nm 10 871.9 ± 246.7** # $ 28050.3 ± 13840.4** ## $ 354.9 ± 141.7 860.7 ± 120.5* ##
OVA + 56 nm 10 515.6 ± 122.4* 4150.5 ± 1657.0 126.7 ± 32.2 600.7 ± 62.8
Six groups were intratracheally inoculated with vehicle, nano particles, OVA, or the combination of OVA and nano particles for 6 wk. Serum 
samples were retrieved 24 h after the last intratracheal instillation. Total IgE and antigen-specific IgG1, IgG2a, and IgE were analyzed using ELISA. 
Results are expressed as mean ± SEM. *P < 0.05 versus vehicle, **P < 0.01 versus vehicle, #P < 0.05 versus OVA, ##P < 0.01 versus OVA, $P < 0.01 
versus nano particles.Respiratory Research 2005, 6:106 http://respiratory-research.com/content/6/1/106
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demonstrated that CB exacerbates airway inflammation
related to antigen in rats [18]. Last and colleagues have
demonstrated that ambient particles with a diameter of
less than 2.5 µm partially exacerbated lung inflammation
related to antigen [17]. However, the comparative study
focusing on the effects of particle size on antigen-related
airway inflammation has never been conducted in vivo. In
the present study, nano particles aggravated antigen-
related airway inflammation, which was confirmed by the
counts of inflammatory leukocytes in BAL fluid and by the
histological assesment. Furthermore, we showed that
nano particles exaggerated goblet cell hyperplasia elicited
by antigen. In overall trends, the enhancing effects were
more prominent with 14 nm nano particles than with 56
nm nano particles. Furthermore, 14 nm nano particles
had obvious adjuvant activity for the antigen-specific pro-
duction of IgG1 and IgE. These results clearly indicate that
nano particles can aggravate antigen-related airway
inflammation in vivo. Also, the effects are greater with
smaller particles than with larger particles. We have previ-
ously examined the effects of DEP on allergic airway
inflammation using 100 µg of DEP in vivo [5,24,25].
Based on the previous studies from our laboratory, we
chose the dosage of 50 µg/body of nano particles, which
can be considered to be involved in 100 µg of DEP as ele-
mentary carbon. Indeed, the enhancing effects of 14 nm
nano particles on the airway inflammation and cytokine
expressions are comparable to those of DEP in the previ-
ous study [5]. Another important point in this study is the
surface area of the nano particles used. Surface area of par-
ticles exposed reportedly correlates magunitude of airway
inflammation [26]. In our study, the surface area of the 14
nm nano particles was 6.7 fold larger than that of 56 nm
nano particles (300 m2/g versus 45 m2/g). Nano particles
with larger surface area are likely to attach more immu-
noregulative molecules than those with smaller surface
area. As a result, smaller nano particles (14 nm) may lead
to more prominent aggravation of antigen-related airway
inflammation than larger nano particles (56 nm) in the
present study. We did not examine the effects of the nano
particles with the same particle number in the present
study. However, the number of smaller nano particles is
larger than that of larger nano particles when the particles
make the same weight. Alternatively, our study has
demonstrated not only the size effects of nano particles,
but also the effects of their surface area and/or the effects
of their number on the antigen-related airway inflamma-
tion. Future independent studies uniforming the surface
area or particle number will provide better widestanding
for the effects of the nano particles on antigen-related air-
way inflammation.
Allergic asthma is often associated with activation of IL-5
gene cluster, a pattern compatible with predominant acti-
vation of Th2-like T-lymphocyte population. IL-5 is essen-
tial for maturation of eosinophils in the bone marrow and
their release into the blood [27,28]. Also, these Th2
cytokines are implicated in the pathogenesis of allergic
reactions via their roles in mediating IgG1 and IgE produc-
tion, and in differentiation, vascular adhesion, recruit-
ment, activation, and survival of eosinophils. In our
study, airway inflammation induced by the combined
administration of nano particles and antigen were con-
comitant with the increased protein levels of IL-5. These
results provide the first evidence that nano particles can
accelerate antigen-related IL-5 expression and subsequent
eosinophilic inflammation.
IL-13 is also recognized to regulate eosinophilic inflam-
mation, and mucus secretion [29]. On the other hand, IL-
6 is believed to participate in airway remodeling [30]. In
the present study, nano particles enhanced the expression
of the proteins in the presence of antigen. Therefore, nano
particles may aggravate mucus hypersecretion and airway
remodeling, at least partly, through the enhanced expres-
sion of IL-13 and IL-6. In fact, the OVA + nano particle
groups showed enhancement in the mucus hypersecre-
tion as compared with the OVA group or the nano particle
groups.
Among chemokines, eotaxin is essential for eosinophil
recruitment in antigen-related airway inflammation
[31,32]. RANTES is a strong chemotactic and activating
factor for eosinophils, and can modulate eosinophil adhe-
sion [33,34]. In fact, our previous studies have confirmed
that the exaggerated allergic airway inflammation induced
by DEP paralleled the local elevation of the inflammatory
proteins [5,22]. In the present study, nano particles
enhanced the expression of these proteins in the presence
of antigen as compared with antigen alone. The results
suggest that nano particles aggravate allergic airway
inflammation, at least in part, via the enhancement of the
local expression of these proteins.
Interestingly, in our study, nano particles challenge
increased the lung level of MCP-1 as compared to vehicle
challenge. Also, the levels were significantly greater in the
OVA + nano particle groups than in the vehicle or the OVA
group. MCP-1 is a CC chemokine, and is chemoattractant
for monocytes [34]. It also has a chemoattractant effect of
CD4+ and CD8+ T lymphocytes [35]. MCP-1 also plays a
role in recruitment of eosinophils to acute and chronic
inflammatory sites [36]. Furthermore, some particles such
as silica [37] and amosite asbestos [38] reportedly can
induce MCP-1 in vitro and in vivo. Thus, our findings indi-
cate that pulmonary exposure to carbon nano particles
may induce MCP-1 expression in the airways. In addition,
the aggravating effects of nano particles on antigen-related
airway inflammation should be mediated, at least in part,
via the enhanced expression of this chemokine.Respiratory Research 2005, 6:106 http://respiratory-research.com/content/6/1/106
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In overall trends, the enhancing effects of nano particles
on local expression of cytokines and chemokines related
to antigen challenge were more prominent with 14 nm
nano particles than with 56 nm nano particles. The differ-
ences in the enhanced expression of the proteins between
the two sizes of nano particles may contribute, at least
partly, to the differences in the magnitude of antigen-
related airway inflammation and goblet cell hyperplasia.
Redox imbalance is a critical factor for tissue injury in var-
ious pulmonary diseases including inflammation such as
asthma [39,40]. Airway macrophages from individuals
with asthma produce more reactive oxidative species
(ROS) than those from control subjects [41]. On the other
hand, nano particles have been implicated to induce and/
or enhance oxidative stress [42]. Furthermore, a recent
study has demonstrated that the same type of nano parti-
cles as we used can induce ROS in the alveolar macro-
phages [43]. We, therefore, evaluated the contribution of
oxidative stress to the deterious effects of nano particles
on antigen-related airway inflammation. 8-OHdG is a
proper marker of the oxidative stress. In our study, immu-
noreactivity of 8-OHdG in the lung was more intense in
the OVA + nano particle groups than in the nano particle
groups or the OVA group. Further, enhanced immunore-
activity for 8-OHdG was detected in alveolar macrophages
as well as polymorphonuclear leukocytes. It is suggested
that the enhanced oxidative stress is involved, at least
partly, in the aggravation of antigen-related airway
inflammation caused by nano particles.
Antigen-specific IgE is thought to contribute to inflamma-
tory cell accumulation after antigen challenge via degran-
ulation of mast cells [44]. On the other hand, IgG with
antigen is a strong agonist for eosinophil degradation in
vitro [45]. Furthermore, late asthmatic reactions are asso-
ciated with IgG antibody [46]. Previous studies have
reported that DEP with antigen demonstrate adjuvant
activity for IgE production in vivo [47] and that those with-
out antigen induce nonspecific IgE response in humans
[48,49]. In addition, we have reported that DEP enhance
antigen-specific production of IgE and IgG induced by
intratracheal challenge with antigen in vivo [5,25]. In the
present study, the combined intratracheal administration
of 14 nm nano particles and antigen showed a significant
greater increase in total IgE and antigen-specific IgG1 and
IgE than the other administration. The enhancement in
the antigen-specific immunogloblin production by 14 nm
nano particles can induce the enhanced release of a variety
of inflammatory mediators such as histamine and
leukotrienes, resulting in aggravated manifestations of
allergic asthma.
Finally, in the real world, we inhale nano particles and
antigen in ambient air, not particle suspension nor
aliquot of antigen. The dose of nano particles injected in
the present study can be estimated to be less than a hun-
dred fold than that we inhale in daily life. Further, real PM
including DEP are complex mixture of carbon, metals,
and organics, which are different from CB used in the
present study. Thus, it remains to be elucidated in future
whether daily inhalation of nano particles with or without
other compounds including organic chemicals than ele-
mentary carbon combined with occasional exposure of
aerosol antigen lead to the same results as the present
study.
Conclusion
The present study has shown evidence that nano particles
can aggravate antigen-related airway inflammation. The
effect may be mediated, at least partly, through the
increased local expression of IL-5 and eotaxin and also by
the modulated expression of IL-13, MCP-1, IL-6, and
RANTES. Furthermore, 14 nm nano particles enhance
total IgE and antigen-specific production of IgG1 and IgE.
These results suggest that nano particles can be a risk for
exacerbation of allergic asthma. The aggravating effect
may be larger with the smaller particles.
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